#healthcareinsights

The US spends a TON on healthcare, and it's only going up! The future of healthcare spending in the United States is a topic of constant debate. But what do the experts say? The CMS Office of the Actuary predicts US health spending to reach a staggering $7.7 trillion by 2032, up from $4.8 trillion in 2023 (7.5% annual growth). This steady increase suggests a long- term trend of rising healthcare costs. https://www.jaspercolin.com/insights/blogs/can-we-afford-to-stay-healthy #JasperColin #HealthcareInsights #HealthcareCosts #FutureofHealthcare #HealthcarePolicy #MedicalExpenses #AffordableCare

AI is rapidly transforming the global life sciences industry, from predictive healthcare to post-market surveillance! Get ready for faster clinical trials, personalized medicine, and even drug repurposing! Matching patients to the right trials in half the time. AI catching diseases earlier and predict future health risks. AI-powered diagnostics saving the healthcare system $100B a year! This is the future of medicine, and it's arriving fast! Read the blog to discover how AI is predicted to impact the life sciences landscape by 2025. #JasperColin #DatatoDecision #AIinHealthcare #DrugDiscovery #HealthcareInsights #FutureofHealth #LifeSciences #MRI

In the ever-evolving world of clinical treatments, a pharmaceutical industry leader faced a challenge: adapting its messaging to meet the changing needs of European physicians. We, at Jasper Colin, stepped in to help them create a strategic positioning for their new drug, ensuring it stood out in a competitive landscape. Our strategic positioning efforts gave the drug a competitive edge, making it a preferred choice among European physicians. Read the full report to dive deeper into our methodology and discover how we transformed the drug's market positioning. #Jaspercolin #StrategicPositioning #pharmaceuticalindustry #ClinicalTreatments #drugmanufacturing #healthcareinsights

PBMs occupy a complex role in the pharmaceutical industry, wielding significant influence over drug pricing, formulary management, and pharmacy benefit programs. While they have contributed to lowering drug costs for insurance companies, their opaque practices, potential for conflicts of interest, and detrimental impact on pharmacies have raised serious concerns. It is crucial to address these issues to ensure that PBMs operate in a transparent, patient-centric, and pharmacy-friendly manner. #jaspercolin #healthcareinsights #healthcareindustry #PBMs #healthcareinnovation #pharmacyoperations #pharmacybusiness